drugset / Trial / NCT01332253

Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy

NCT01332253

Phase 3 Completed 161 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The hypothesis is that a single, pre-operative dose of intravenous ibuprofen will significantly reduce post-operative fentanyl use compared to placebo.

Timeline

Start
2011-07
Primary completion
2012-07
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.